Hans‐Peter Stoll - Concepedia

Author

Hans‐Peter Stoll

Also Known As

H STOLL, H Stoll, H. -P. Stoll, H. P. Stoll, H. Stoll, H.-P. Stoll, HANS-PETER STOLL, Hans-Peter Stoll, Hans‐Peter Stoll

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Hôpital Rangueil Institut Cardiovasculaire Paris Sud Inserm Assistance Publique – Hôpitaux de Paris Générale de Santé

About

Hans‐Peter Stoll is an author at Hôpital Rangueil specializing in medicine, cardiovascular disease, and percutaneous coronary intervention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	855
2	Engineering	1	1	42
3	Health Sciences	1	1	42
4	Public Health	1	1	24
5	Anatomy	1	1	88

Hans‐Peter Stoll

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk Philip Urban, Ian T. Meredith, Alexandre Abizaid, New England Journal of Medicine	2015	790
Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice Philip Urban, Anthony Gershlick, Giulio Guagliumi, Circulation	2006	321
A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting With the Sirolimus-Eluting Stent in Patients With Ischemic Peripheral Arterial Disease Dierk Scheinert, Konstantinos Katsanos, Thomas Zeller, Journal of the American College of Cardiology ThrombosisSirolimus-eluting StentEndovascular TechniqueCardiovascular DiseasePeripheral Intervention	2012	268
Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents Marie‐Claude Morice, Patrick W. Serruys, Paul Barragan, Journal of the American College of Cardiology Percutaneous Coronary InterventionSirolimus-eluting Coronary StentsCardiovascular DiseaseAtherosclerosisEndovascular Management	2007	223
Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty) Christian Spaulding, Emmanuel Teíger, Philippe Commeau, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionCardiovascular DiseaseAcute Myocardial InfarctionFour-year Follow-upMedicine	2011	124
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents Philippe Garot, Marie‐Claude Morice, Damras Tresukosol, Journal of the American College of Cardiology	2016	121
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon, European Heart Journal	2019	119
One-Year Results of the SCORPIUS Study Dietrich Baumgart, Frank M. Baer, Franz Hartmann, Journal of the American College of Cardiology Clinical NeurologySurgeryAnatomyMedicineOrthopaedic Surgery	2007	88
Sirolimus-Elutin<u>g</u> versus Bare-Metal Low-Profile Stent for <u>R</u>enal <u>A</u>rtery <u>T</u>reatment (GREAT Trial): Angiographic Follow-up after 6 Months and Clinical Outcome up to 2 Years M. Zähringer, Marc Sapoval, Peter M. T. Pattynama, Journal of Endovascular Therapy	2007	84
S.M.A.R.T. Self-Expanding Nitinol Stent for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (STROLL): 1-Year Outcomes William A. Gray, Andrew J. Feiring, Marco Cioppi, Journal of Vascular and Interventional Radiology 1-Year OutcomesEndovascular TechniqueCardiovascular DiseaseMedicinePeripheral Intervention	2014	64

Page 1